Alimentary Pharmacology & Therapeutics

Review article: current status of liver transplantation in HIV-infected patients
pp. 993-1000(8)
Authors: Neff, G. W.; Sherman, K. E.; Eghtesad, B.; Fung, J.

Review article: ¹³C-urea breath test in the diagnosis of Helicobacter pylori infection - a critical review
pp. 1001-1017(17)
Authors: Gisbert, J. P.; Pajares, J. M.

Review article: orofacial granulomatosis
pp. 1019-1027(9)
Authors: Leão, J. C.; Hodgson, T.; Scully, C.; Porter, S.

Review article: is there a link between micronutrient malnutrition and Helicobacter pylori infection?
pp. 1029-1034(6)
Authors: Salgueiro, J.; Zubillaga, M.; Goldman, C.; Barrado, A.; Martinez Sarrasague, M.; Leonardi, N.; Boccio, J.

Systematic review: is ingestion of paracetamol or non-steroidal anti-inflammatory drugs associated with exacerbations of inflammatory bowel disease?
pp. 1035-1043(9)
Authors: Forrest, K.; Symmons, D.; Foster, P.

Meta-analysis: the diagnostic value of alarm symptoms for upper gastrointestinal malignancy
pp. 1045-1052(8)
Authors: Fransen, G. A. J.; Janssen, M. J. R.; Muris, J. W. M.; Laheij, R. J. F.; Jansen, J. B. M. J.

Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease
pp. 1053-1062(10)
Authors: Fabrizi, F.; Martin, P.; Dixit, V.; Bunnapradist, S.; Dulai, G.

Meta-analysis: the detection of pancreatic malignancy with positron emission tomography
pp. 1063-1070(8)
Authors: Orlando, L. A.; Kulasingam, S. L.; Matchar, D. B.

Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti- Helicobacter pylori quadruple therapies
pp. 1071-1082(12)
Authors: Fischbach, L. A.; Zanten, S. V.; Dickason, J.

A novel diagnostic tool for detecting oesophageal pathology: the PillCam oesophageal video capsule
pp. 1083-1089(7)
Authors: Eliakim, R.; Yassin, K.; Shlomi, I.; Suissa, A.; Eisen, G. M.

Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs
pp. 1091-1097(7)
Authors: Pilotto, A.; Franceschi, M.; Leandro, G.; Paris, F.; Cascavilla, L.; Longo, M. G.; Niro, V.; Andriulli, A.; Scarcelli, C.; Di Mario, F.

Esomeprazole 40 mg i.v. provides faster and more effective intragastric acid control than pantoprazole 40 mg i.v.: results of a randomized study
pp. 1099-1104(6)
Authors: Wilder-Smith, C. H.; Röhss, K.; Bondarov, P.; Hallerbäck, B.; Svedberg, L.-E.; Ahlbom, H.

Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis
pp. 1105-1114(10)
Authors: Bochenek, W. J.; Mack, M. E.; Fraga, P. D.; Metz, D. C.

Outcomes in elderly patients following surgery for colorectal cancer in the veterans affairs health care system
pp. 1115-1124(10)
Authors: Rabeneck, L.; Davila, J. A.; Thompson, M.; El-Serag, H. B.

Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer
pp. 1125-1131(7)
Authors: Wolfsen, H. C.; Hemminger, L. L.; Wallace, M. B.; DeVault, K. R.

Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis
pp. 1133-1141(9)
Authors: Kato, K.; Mizuno, S.; Umesaki, Y.; Ishii, Y.; Sugitani, M.; Imaoka, A.; Otsuka, M.; Hasunuma, O.; Kurihara, R.; Iwasaki, A.; Arakawa, Y.

Anti- Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features
pp. 1143-1152(10)
Authors: Annese, V.; Piepoli, A.; Perri, F.; Lombardi, G.; Latiano, A.; Napolitano, G.; Corritore, G.; Vandewalle, P.; Poulain, D.; Colombel, J. F.; Andriulli, A.

Symptomatic gastro-oesophageal reflux, arousals and sleep quality in patients undergoing polysomnography for possible obstructive sleep apnoea
pp. 1153-1159(7)
Authors: Guda, N.; Partington, S.; Vakil, N.

Do physicians correctly assess patient symptom severity in gastro-oesophageal reflux disease?
pp. 1161-1169(9)
Authors: Fallone, C. A.; Guyatt, G. H.; Armstrong, D.; Wiklund, I.; Degl'Innocenti, A.; Heels-Ansdell, D.; Barkun, A. N.; Chiba, N.; Zanten, S. J. O. V.; El-Dika, S.; Austin, P.; Tanser, L.; Schünemann, H. J.

Classification of dyspepsia and response to treatment with proton-pump inhibitors
pp. 1171-1179(9)
Author: Meineche-Schmidt, V.

Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial
pp. 1181-1188(8)
Authors: Nista, E. C.; Candelli, M.; Cremonini, F.; Cazzato, I. A.; Zocco, M. A.; Franceschi, F.; Cammarota, G.; Gasbarrini, G.; Gasbarrini, A

High-dose vitamin E supplementation does not diminish ribavirin-associated haemolysis in hepatitis C treatment with combination standard α-interferon and ribavirin
pp. 1189-1193(5)
Authors: Saeian, K.; Bajaj, J. S.; Franco, J.; Knox, J. F.; Daniel, J.; Peine, C.; McKee, D.; Varma, R. R.; Ho, S.

Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications
pp. 1195-1203(9)
Authors: Vandvik, P. O.; Wilhelmsen, I.; Ihlebæk, C.; Farup, P. G.

Agreements among traditional Chinese medicine practitioners in the diagnosis and treatment of irritable bowel syndrome
pp. 1205-1210(6)
Authors: Sung, J. J. Y.; Leung, W. K.; Ching, J. Y. L.; Lao, L.; Zhang, G.; Wu, J. C. Y.; Liang, S. M.; Xie, H.; Ho, Y. P.; Chan, L. S.; Berman, B.; Chan, F. K. L.